[Federal Register: May 13, 2004 (Volume 69, Number 93)]
[Notices]               
[Page 26613-26614]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13my04-133]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

 
Advisory Committee; Renewals

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the 
renewal of certain FDA advisory committees by the Commissioner of Food 
and Drugs (the Commissioner). The Commissioner has determined that it 
is in the public interest to renew the charters of the committees 
listed in the following table for an additional 2 years beyond charter 
expiration date. The new charters will be in effect until the dates of 
expiration listed in the following table. This notice is issued under 
the Federal Advisory Committee Act of October 6, 1972 (Public Law 92-
463 (5 U.S.C. app. 2)).

DATES: Authority for these committees will expire on the dates 
indicated in the following table unless the Commissioner formally 
determines that renewal is in the public interest.

[[Page 26614]]



------------------------------------------------------------------------
              Name of committee                    Date of expiration
------------------------------------------------------------------------
National Mammography Quality Assurance         July 6, 2005
 Advisory Committee
Nonprescription Drugs Advisory Committee       August 27, 2005
Advisory Committee on Special Studies          December 2, 2005
 Relating to the Possible Long-Term Health
 Effects of Phenoxy Herbicides and
 Contaminants
Food Advisory Committee                        December 18, 2005
Vaccines and Related Biological Products       December 31, 2005
 Advisory Committee
Advisory Committee for Pharmaceutical Science  January 22, 2006
Gastrointestinal Drugs Advisory Committee      March 3, 2006
Advisory Committee for Reproductive Health     March 23, 2006
 Drugs
Arthritis Advisory Committee                   April 5, 2006
Veterinary Medicine Advisory Committee         April 24, 2006
------------------------------------------------------------------------


FOR FURTHER INFORMATION CONTACT: Linda A. Sherman, Advisory Committee 
Oversight and Management Staff (HF-4), Food and Drug Administration, 
5600 Fishers Lane, Rockville, MD 20857, 301-827-1220.

    Dated: May 5, 2004.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 04-10832 Filed 5-12-04; 8:45 am]

BILLING CODE 4160-01-S